Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Antihyperalgesic effects of SB-235863 presented at Society for Neuroscience meeting

Nov. 20, 1998

DBO-83: novel nicotinic agonist with antiamnestic activity

Nov. 20, 1998

Wide series of 5-HT antagonists from Eisai useful as antispastic agents, central muscle relaxants

Nov. 19, 1998

Phytoanalgesic agent WS-1531 shows limited efficacy, good safety in treating back pain

Nov. 19, 1998

Igmesine: mode of action and preclinical antidepressant activity

Nov. 18, 1998

Potent and selective 5-HT1A/5-HT1B/5-HT1D receptor antagonists discovered at Pierre Fabre

Nov. 18, 1998

Putative cognition enhancer CR-2249 also exerts anxiolytic, antidepressant effects

Nov. 17, 1998

New dopamine D4 antagonist from Warner-Lambert characterized in preclinical studies

Nov. 17, 1998

Neuroprotective effects of HU-211 in soman-treated rats

Nov. 17, 1998

GPI-6150: data provide further support for development as a treatment for stroke

Nov. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...